Stockreport

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu [Yahoo! Finance]

Traws Pharma, Inc.  (TRAW) 
PDF Phase 1 dosing completed in healthy volunteers Potent inhibition of drug-resistant and bird flu viruses in vitro In vivo study in mice, with H5N1 isolated from an i [Read more]